Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516473 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'RNAi/MicroRNA Market Report' returned 32 results - Page 1 of 2

  Sort by   
  Sorted by Rank Top-Bottom

RNAi - Technologies, Markets and Companies  
Jain PharmaBiotech, June 2012, Pages: 485
nucleotide RNAs termed siRNAs that are used in a sequence-specific manner to recognize and destroy complementary RNA. The report compares RNAi with other antisense approaches using oligonucleotides, aptamers


RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011  
Takeda Pacific, July 2007, Pages: 131
RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011 This report assesses the RNA interference market for drug R&D. RNA interference (RNAi) has been hailed in the


RNA interference (RNAi) - Global Strategic Business Report  
Global Industry Analysts, Inc., April 2011, Pages: 802
institutions has witnessed a substantial growth. The US and Europe together account for a lion’s share of the global RNAi market, as stated by the new Global Industry Analysts' market research report on RNA


Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics  
Business Insights, June 2007, Pages: 244
litigation? MicroRNA Tuschl III patents Zamore and other patents Regulatory considerations for RNAi therapies Conclusions Chapter 8 RNAi markets and trends Summary Introduction The RNAi market


The Future of RNAi Therapeutics: Drug Pipelines and Prospects  
Business Insights, Sep 2008, Pages: 253
satisfaction and five new Phase II/III RNAi agents profiled in this report." RNA interference continues to offer significant promise for a host of therapeutic treatments. Potentially any disease-causing gene


Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities  
PharmaVision, July 2009, Pages: 225
neurological conditions. CHAPTER 1 RNA INTERFERENCE & DELIVERY - Key Findings - Introduction - RNAi a Natural Phenomenon - Antisense technologies - RNAi silencing agents - RNA silencing pathways - micro


RNA Interference Markets  
TriMark Publications, Dec 2008, Pages: 147
study. This is known as gene knockdown. This field has rapidly emerged as a fast-growing new market. The purpose of this report is to review the market for RNAi testing equipment and supplies. RNAi is a


Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma  
GBI Research, Feb 2010, Pages: 89
into the unmet needs in the pharmaceutical and healthcare market and potential segments where RNA therapies can prove to be useful. This pharma report also delves deep into the market potential that RNA


The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics  
Business Insights, May 2005
report which analyzes the latest trends in the RNAi market, allowing pharmaceutical companies to decide which areas of RNAi technologies to invest in, to improve drug attrition rates and develop new


Top 10 Drug Discovery Technologies – Strategic Analysis And Global Forecasts  
Markets and Markets, Nov 2010, Pages: 311
. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report also provides more than 20 company profiles covering all the sub-segments. What


The Exploding RNAi Market & Future Direction Translating the Genome into a Large Market by 2009  
Fuji-Keizai USA, Inc, Feb 2006, Pages: 130
Stranded RNA (dsRNA) 1.1.3 Short interfering RNA; Small interfering RNA (siRNA) 1.1.4 Short Hairpin RNA (shRNA) 1.1.5 DNA-directed RNAi (ddRNAi) 1.1.6 MicroRNA (miRNA) 1.2 Current US RNAi Market


Antivirals: Novel Targets, Technologies, and Dealmaking  
Decision Resources, Inc., Feb 2010, Pages: 32
technologies, including RNA interference (RNAi), to the development of novel antivirals. Which companies are developing RNA and RNAi-based antivirals? Which RNA-based technologies are the most advanced in


Cytogenetics - Technologies, Markets and Companies  
Jain PharmaBiotech, June 2012, Pages: 225
reaction RNA interference and cytogenetics RNA-induced transcriptional silencing complex Single cell genetics by siRNA ablation RNAi and cancer cytogenetics Role of miRNAs in cancer cytogenetics


Drug Delivery in Cancer - Technologies, Markets and Companies  
Jain PharmaBiotech, June 2012, Pages: 639
diagnosis and therapeutics of cancer Antisense compounds in clinical trials RNA interference Basics of RNAi Comparison of antisense and RNAi RNAi applications in oncology siRNA-based cancer immunotherapy


Gene Therapy - Technologies, Markets and Companies  
Jain PharmaBiotech, June 2012, Pages: 658
such as RNA interference (RNAi), further increasing the therapeutic applications. This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic


Progress in RNA-Based Therapeutics  
Decision Resources, Inc., Aug 2005, Pages: 19
(ASOs), RNA interference (RNAi), and microRNA (miRNA). Companies have been testing ASOs in the clinic for ten years, and one antisense product, fomivirsen (Isis Pharmaceuticals’ Vitravene), is on the


Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi  
Business Insights, April 2005, Pages: 186
. Key questions answered in this report - What will the market for lab-on-a-chip (LOC), nanoenabled drug discovery and RNAi technology be worth in 2012? - How can these three technologies be effectively


Tissue Engineering Related Tools and Analytical Products: Current & Future Markets U.S. & EU Trends & Commercial Implications  
Fuji-Keizai USA, Inc, Jan 2011, Pages: 134
MicroRNA Screening Equipment 4.3 Cell Culture Equipment for Tissue Engineering Common Research Item (4.3.1 – 4.3.7) - Market Overview - Leading Players (Company Name, Contact Information, Public or Private


Tissue Engineering Related Tools and Analytical Products: Current & Future Markets U.S. & EU Trends & Commercial Implications (Japanese version)  
Fuji-Keizai USA, Inc, Feb 2011, Pages: 122
MicroRNA Screening Equipment 4.3 Cell Culture Equipment for Tissue Engineering Common Research Item (4.3.1 – 4.3.7) - Market Overview - Leading Players (Company Name, Contact Information, Public or Private


Beyond Expression Arrays: Emerging Applications for Genomic Microarray Technology  
Beachhead Consulting, Sep 2006
microarray applications on the healthcare and pharmaceutical industries is examined in this report and reveals the market for the latest products and technologies as potentially one of the fastest growing


Results:  First -   Prev -   1 -   2 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds